Literature DB >> 9798215

Anomalies of genetic development as predictors of oculo-visual abnormalities in velo-cardio-facial syndrome.

S G Crewther1, P M Kiely, L L Kok, D P Crewther.   

Abstract

BACKGROUND: Subjects with velo-cardio-facial syndrome (VCFS) were assessed to determine whether the learning disabilities (LDs) characterizing the syndrome are compounded by visual function deficits, which would be predicted on the basis of the proposed embryonic derivation of the genetic anomaly.
METHODS: Twelve subjects diagnosed with VCFS underwent a vision screening with emphasis on binocular function.
RESULTS: Subjects exhibited deficits in accommodation (N = 5), convergence (N = 7), fusional reserves (N = 9), and stereopsis (N = 10). Three patients were strabismic at near. No patient was in the clinically normal range for all tests of binocular function.
CONCLUSIONS: Individuals with VCFS have a chromosome 22 deficit thought to alter the migration of neural crest (NC) cells, which are the embryonic precursors of the autonomic innervation of the smooth muscle components of the eye and of cranial nerves III, IV, and VI. It was predicted that VCFS patients would demonstrate reduced accommodation and convergence flexibility, which would reduce visual comfort for near work. The pathological etiology of the visual anomalies suggests that if visual training is not successful, these patients should be provided with a suitable optical reading correction from an early age.

Entities:  

Mesh:

Year:  1998        PMID: 9798215     DOI: 10.1097/00006324-199810000-00020

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  2 in total

1.  Ocular findings in children with a microdeletion in chromosome 22q11.2.

Authors:  Ingele Casteels; Patricia Casaer; Marc Gewillig; Ann Swillen; Koenraad Devriendt
Journal:  Eur J Pediatr       Date:  2007-08-18       Impact factor: 3.183

2.  Ocular findings in 22q11.2 deletion syndrome: A systematic literature review and results of a Dutch multicenter study.

Authors:  Emma N M M von Scheibler; Emy S van der Valk Bouman; Myrthe A Nuijts; Noël J C Bauer; Tos T J M Berendschot; Pit Vermeltfoort; Levinus A Bok; Agnies M van Eeghen; Michiel L Houben; Thérèse A M J van Amelsvoort; Erik Boot; Michelle B van Egmond-Ebbeling
Journal:  Am J Med Genet A       Date:  2021-11-12       Impact factor: 2.578

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.